Am J Transplant, Volume 21, Suppl 3 Archives - Page 96 of 139 - ATC Abstracts

2021 American Transplant Congress
Update on Pancreas Retransplantation- A Registry Analysis
A. Gruessner, J. Renz, S. Saggi, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: A successful pancreas transplant provides patients with brittle diabetes the opportunity of good long-term metabolic control. While initially more and more retransplants were performed,…
2021 American Transplant Congress
COVID-19 Transmission within One Year from Pancreas and Kidney Recipients
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty surrounding the transmission of COVID-19. It was recently published that in the general population, household contacts have a…
2021 American Transplant Congress
The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
D. Xu¹, K. Richards¹, K. Zheng¹, H. Patel², F. Cardarelli², J. A. Pena³, A. Aala²
¹Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, ²Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ³Pathology, Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: High intrapatient variability (IPV) and low time in therapeutic range (TTR) of tacrolimus (TAC) may increase the risk of developing de novo donor-specific antibodies…
2021 American Transplant Congress
Impact of Traveling for Transplant on Access to and Outcomes from Kidney and Liver Transplantation
K. Ross-Driscoll¹, R. Lynch¹, D. Axelrod², R. Patzer¹
¹Emory University, Atlanta, GA, ²University of Iowa, Ames, IA
*Purpose: Newly developed transplant referral regions (TRRs) can be used to understand how and why patients travel outside of their home transplant center to receive…
2021 American Transplant Congress
Kidney Transplantation in Times of Covid-19 – Decision Analysis in the Canadian Context
I. Yanev¹, M. Gagnon¹, M. Cheng², S. Paraskevas², D. Kumar³, A. Dragomir⁴, R. Sapir-Pichhadze⁴
¹McGill University, Montreal, QC, Canada, ²McGill University Health Centre, Montreal, QC, Canada, ³University Health Network, Toronto, ON, Canada, ⁴Research Institute of McGill University Health Centre, Montreal, QC, Canada
*Purpose: The coronavirus disease 2019 (COVID-19) pandemic significantly impacted the field of transplantation across Canada. In this study, we outline the implications of COVID-19 related…
2021 American Transplant Congress
Utility of Follow-up Biopsies After Acute Rejection in Pediatric Kidney Transplantation
S. S. Raza¹, V. Hauptfeld-Dolejsek¹, F. Rosenblum¹, E. C. Mroczek-Musulman², D. R. Kelly², M. Seifert¹
¹Department of Nephrology, UAB School of Medicine, Birmingham, AL, ²Children’s of Alabama, Birmingham, AL
*Purpose: Treatment of acute kidney transplant rejection in children is often guided by creatinine-based estimates of GFR (eGFR) that may lack sensitivity to determine the…
2021 American Transplant Congress
Impact of CHA2DS2-VASc Score on Postoperative Mortality Following Kidney Transplant
J. Klein¹, M. Rangel¹, Z. Spigel², E. Hollinger¹, D. Olaitan¹, M. Hertl¹, E. Chan¹
¹Surgery, Rush University Medical Center, Chicago, IL, ²Surgery, Allegheny Health Network, Pittsburgh, PA
*Purpose: This study aimed to assess the correlation between CHA2DS2-VASc score and postoperative kidney transplant survival. The conditions captured in the CHA2DS2-VASc score are commonly…
2021 American Transplant Congress
Liver Biopsy as a Predictor in Risk Stratification for Heart Transplant Candidates
S. Tolia¹, T. Al Saadi¹, N. Narang², A. Joshi², C. Sciamanna², S. Pauwaa², G. Macaluso², M. Dia², A. Tatooles³, P. Pappas³, W. Cotts², A. Andrade²
¹Internal Medicine, Advocate Christ Medical Center, Oak Lawn, IL, ²Cardiology, Advocate Christ Medical Center, Oak Lawn, IL, ³Cardiovascular Surgery, Advocate Christ Medical Center, Oak Lawn, IL
*Purpose: Patients undergoing workup for Orthotopic Heart Transplant (OHT) undergo multi-organ evaluation for risk stratification. While cirrhosis is a known predictor of poor outcomes in…
2021 American Transplant Congress
The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis
J. Kumar¹, J. Pyda², I. Reccia³, F. VIrdis⁴, P. Bachul¹, R. Barth¹, Y. Becker¹, J. Fung¹, P. Witkowski¹
¹University of Chicago, Chicago, IL, ²Beth Israel, Boston, MA, ³Imperial College, London, United Kingdom, ⁴Royal London, London, United Kingdom
*Purpose: To determine pooled prevalence of clinical outcomes among hospitalized kidney transplant recipients with COVID-19 through meta-analysis.*Methods: A systematic database search between Dec1, 2019- Dec1,…
2021 American Transplant Congress
Leflunomide Therapy for Treatment of Bk Viremia in Pediatric Kidney Transplant Recipients
A. Aldieri¹, M. Chandran², D. Matossian³, B. Magella⁴, D. Lazear⁴, M. Bock², E. Blanchette²
¹Children's Hospital Colorado, Denver, CO, ²Children's Hospital Colorado, Aurora, CO, ³Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ⁴Cincinnati Children's Hospital Medical Center, Cincinnati, OH
*Purpose: BK viremia (BKV) after kidney transplantation (KT) poses significant risk for BK virus-associated nephropathy (BKVN) and impacts graft survival. Conventional treatment involves reduction of…